Correction of murine Rag1 deficiency by self-inactivating lentiviral vector-mediated gene transfer. (Q45870373)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21617701%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

title

Correction of murine Rag1 deficiency by self-inactivating lentiviral vector-mediated gene transfer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21617701%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21617701%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Chantal Lagresle

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21617701%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Rob C Hoeben

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21617701%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Jacques Van Dongen

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21617701%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

K Pike-Overzet

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21617701%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

M Rodijk

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21617701%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Y-Y Ng

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21617701%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

M R M Baert

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21617701%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

A Schambach

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21617701%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

F Zhang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21617701%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

S Hacein-Bey-Abina

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21617701%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

A C Lankester

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21617701%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

R G M Bredius

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21617701%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

G J A Driessen

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21617701%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

A J Thrasher

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21617701%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

C Baum

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21617701%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

F J T Staal

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21617701%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

publication date

27 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21617701%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21617701%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21617701%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21617701%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

1471-1483

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21617701%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2011.106

2 February 2020

exact match

0 references

cites work

Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee Meeting in Budapest, 2005

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

T-B+NK+ severe combined immunodeficiency caused by complete deficiency of the CD3zeta subunit of the T-cell antigen receptor complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

A new type of radiosensitive T-B-NK+ severe combined immunodeficiency caused by a LIG4 mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

RAG mutations in human B cell-negative SCID.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

Retroviral transduction of IL-7Ralpha into IL-7Ralpha-/- bone marrow progenitors: correction of lymphoid deficiency and induction of neutrophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

Complete correction of murine Artemis immunodeficiency by lentiviral vector-mediated gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

Gene therapy of RAG-2-/- mice: sustained correction of the immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

Long-term immune reconstitution in RAG-1-deficient mice treated by retroviral gene therapy: a balance between efficiency and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

Sola dosis facit venenum. Leukemia in gene therapy trials: a question of vectors, inserts and dosage?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

Transcription start regions in the human genome are favored targets for MLV integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

Retroviral DNA integration: viral and cellular determinants of target-site selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

Restoration of human B-cell differentiation into NOD-SCID mice engrafted with gene-corrected CD34+ cells isolated from Artemis or RAG1-deficient patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

Correction of B-cell development in Btk-deficient mice using lentiviral vectors with codon-optimized human BTK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

RAG-1-deficient mice have no mature B and T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

A ubiquitous chromatin opening element (UCOE) confers resistance to DNA methylation-mediated silencing of lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

Identification of two catalytic residues in RAG1 that define a single active site within the RAG1/RAG2 protein complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

Effects of rare codon clusters on high-level expression of heterologous proteins in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

Physiological promoters reduce the genotoxic risk of integrating gene vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

Transgene optimization significantly improves SIN vector titers, gp91phox expression and reconstitution of superoxide production in X-CGD cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

Efficacy of gene therapy for X-linked severe combined immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

Differential biological role of CD3 chains revealed by human immunodeficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

7 January 2021

Identical mutations in RAG1 or RAG2 genes leading to defective V(D)J recombinase activity can cause either T-B-severe combined immune deficiency or Omenn syndrome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

7 January 2021

Interaction of human immunodeficiency virus-derived vectors with wild-type virus in transduced cells.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

7 January 2021

A third-generation lentivirus vector with a conditional packaging system

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

7 January 2021

Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

7 January 2021

Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

7 January 2021

Codon and mRNA Sequence Optimization of Microdystrophin Transgenes Improves Expression and Physiological Outcome in Dystrophic mdx Mice Following AAV2/8 Gene Transfer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

7 January 2021

A regulatory role for recombinase activating genes, RAG-1 and RAG-2, in T cell development

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.106

7 January 2021

Identifiers

DOI

10.1038/LEU.2011.106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21617701%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

2 February 2020

1018437224

0 references

1 reference